Hormone Replacement Therapy

Summary

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the recent FDA advisory committee discussion on the risks and benefits of HRT, on (a) product labelling and (b) patient information; and wheth

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 17 November 2025

   Written question

   To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the recent FDA advisory committee discussion on the risks and benefits of HRT, on (a) product labelling and (b) patient information; and wheth

   Source: Commons

2. 25 November 2025

   Answer

   The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department which regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring that medicines ...

   Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• · Department of Health and Social Care · Answering body

Related records

No cross-record relationships stored yet.